Ennovent

Ennovent generates deal flow through its own accelerator programs, which operate on the ground in key markets such as India and East Africa. These programs attract hundreds of early-stage applicants seeking grant funding and technical assistance. The firm selects the most promising ventures for its commercial investment track after observing their performance during the acceleration phase, creating a proprietary pipeline that external fund managers generally do not see.

Ennovent operates a hybrid model that includes both grant-funded accelerator programs and a direct investment vehicle. The accelerator is typically supported by development finance institutions and corporate foundations, while the investment vehicle makes equity commitments from a pooled commercial capital base. This structure allows Ennovent to nurture companies at the pre-revenue stage and then back them with priced equity as they grow.

Ennovent focuses on the earliest stages of venture formation, including seed and start-up rounds. Through its accelerator, the firm works with founders at the prototype and pilot phase, often before any institutional capital has entered. Its direct investment activity concentrates on enterprises that have demonstrated early market traction and are ready to scale their operations across multiple regions.

Ennovent concentrates its investment and program activity in South Asia and Sub-Saharan Africa. India represents a core market for the firm, where it has run multiple accelerator cohorts and built a network of local partners. East Africa, particularly Kenya, is a secondary focus, with the firm engaging in ventures related to distributed infrastructure and last-mile distribution.

Ennovent exclusively engages in direct company-level investments and programmatic acceleration. The firm does not operate as a fund-of-funds and does not make commitments to external general partners. All capital deployment flows through its own accelerator selection process and its proprietary direct investment vehicle.